Corrigendum: Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease

Sci Rep. 2016 Feb 12:6:20750. doi: 10.1038/srep20750.
No abstract available

Publication types

  • Published Erratum